Form D · Other

Hemex Health, Inc.

Portland, OR · CIK 0001686615

Offering snapshot reported Mar 29, 2018 · SEC filing

Reported sold
$930K
Offering amount: $930K
Investors reported
27
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 19, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 29, 2018Initial$930,000No comparison27SEC filing
Mar 16, 2018Initial$0No comparison1SEC filing
Dec 7, 2017Amendment$3,009,500$2,699,500vs Jan 25, 201746SEC filing
Jan 25, 2017Amendment$310,000$210,000vs Oct 5, 20169SEC filing
Oct 5, 2016Initial$100,000No comparison2SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-308884

Source: Form D, filed Mar 29, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Prakash Agarwal Director
Peter Galen Director, Executive
Susan Morgensztern Director
Annette Mulee Director
Patricia White Seminario Director, Executive
Mohan Uttarwar Director

Issuer details

Industry: Other (See others in industry)

Address:
4640 Sw Macadam Avenue Suite 250
Portland, OR, 97239